
Currently out of the existing stock ratings of Ahu Demir, 2 are a HOLD (11.11%), 16 are a BUY (88.89%).
Analyst Ahu Demir, has had 35% of price targets met with an average potential upside of 34.37%, reached in 93 days on average. Previously, Ahu Demir worked at LADENBURG, NOBLE CAPITAL.
Ahu Demir has documented 34 price targets and ratings displayed on 11 stocks. The coverage was on Healthcare, Basic Materials, Technology sectors.
Most recent stock forecast was given on EVAX, Evaxion Biotech AS at 02-Apr-2024.
Analyst best performing recommendations are on ONTX (ONCONOVA THERAPEUTICS).
The best stock recommendation documented was for ONTX (ONCONOVA THERAPEUTICS) on 12/22/2020. The price target of $6.9 was fulfilled within 1 day with a profit of $0.47 (7.31%), with a performance score of 73.09.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 31-Oct-2022
$16
4 years 21 days ago
(31-Oct-2022)
0/1 (0%)
$12 (300.00%)
Buy Since 07-Dec-2020
$0.55
4 years 1 months 1 days ago
(20-Oct-2022)
2/2 (100%)
$-0.13 (-19.12%)
50
Buy Since 21-Dec-2021
$18
4 years 3 months 5 days ago
(16-Aug-2022)
0/2 (0%)
$9.25 (105.71%)
Buy Since 10-Jun-2020
$6
4 years 7 months 22 days ago
(30-Mar-2022)
0/2 (0%)
$2.05 (51.90%)
Buy Since 21-Dec-2021
$12
$18
4 years 7 months 22 days ago
(30-Mar-2022)
0/3 (0%)
$8 (200.00%)